Key statistics
On Tuesday, Transmedics Group Inc (8T8:FRA) closed at 114.80, -12.23% below its 52-week high of 130.80, set on Dec 02, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 113.75 |
|---|---|
| High | 114.80 |
| Low | 112.00 |
| Bid | 116.10 |
| Offer | 118.10 |
| Previous close | 114.10 |
| Average volume | 168.20 |
|---|---|
| Shares outstanding | 34.17m |
| Free float | 33.17m |
| P/E (TTM) | 57.27 |
| Market cap | 4.66bn USD |
| EPS (TTM) | 2.38 USD |
Data delayed at least 15 minutes, as of Feb 10 2026 19:41 GMT.
More ▼
Press releases
- TransMedics to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
- TransMedics Receives Full and Unconditional FDA IDE Approval for Next-Generation OCS Heart ENHANCE Trial
- TransMedics Announces New Global Headquarters and Expansion at Assembly Innovation Park in Somerville, Massachusetts
- TransMedics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
- TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- TransMedics to Participate in the Piper Sandler 37th Annual Healthcare Conference
More ▼
